Anna Bogusiewicz Selected Research

beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)

1/2012	Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design.
11/2011	Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans.
8/2006	Lymphocyte propionyl-CoA carboxylase and its activation by biotin are sensitive indicators of marginal biotin deficiency in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Bogusiewicz Research Topics

Disease

9	Biotin deficiency 01/2015 - 08/2006
1	Anemia 11/2013

Drug/Important Bio-Agent (IBA)

5	Carnitine (L-Carnitine)FDA LinkGeneric 01/2015 - 12/2010
5	Biotin (Vitamin H)FDA Link 01/2015 - 08/2006
3	Biomarkers (Surrogate Marker)IBA 01/2015 - 05/2010
3	Propionyl-Coenzyme A Carboxylase (Propionyl CoA Carboxylase)IBA 01/2012 - 08/2006
3	beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)IBA 01/2012 - 08/2006
3	Indicators and Reagents (Reagents)IBA 03/2011 - 08/2006
2	Acyl Coenzyme A (Acyl CoA)IBA 01/2015 - 09/2012
1	propionylcarnitineIBA 01/2015
1	3-hydroxyisovalerylcarnitineIBA 01/2015
1	Acetylcarnitine (Alcar)IBA 01/2015
1	Fetal Hemoglobin (Hemoglobin F)IBA 11/2013
1	AntigensIBA 11/2013
1	AvidinIBA 01/2012
1	Leucine (L-Leucine)FDA Link 11/2011
1	CreatinineIBA 03/2011
1	EnzymesIBA 12/2010
1	TeratogensIBA 08/2006